IP Library › Granted Patent US 12,569,595
Granted Patent B2
US 12,569,595 · App. 17/806,041 · Granted Mar 10, 2026

Bioprosthetic tissue preparation

Inventors: Bin Tian (Irvine, CA); Angela B. De La Fuente (San Clemente, CA); Gregory A. Wright (Orange, CA); Jingjia Han (Irvine, CA); Hao Shang (Irvine, CA)
Assignee: Edwards Lifesciences Corporation
A61L27/3687A61L2430/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,595
App. No.
17/806,041
Granted
Mar 10, 2026
Kind
B2
Abstract

Methods for preparing bioprosthetic tissue are provided. In some instances, bioprosthetic tissue is treated to remove antigenic biomolecules. In some instances, prepared bioprosthetic tissues are incorporated into a medical device.

Claims (40)

1 . A method to prepare bioprosthetic tissue for clinical or preclinical use, comprising:

fixing the bioprosthetic tissue;

solubilizing hydrophilic biomolecules within a bioprosthetic tissue utilizing a reducing agent;

solubilizing lipophilic biomolecules within the bioprosthetic tissue utilizing a nonionic detergent, a zwitterionic detergent, an ionic detergent, or a plurality of detergents comprising at least one nonionic detergent and at least one ionic detergent;

enzymatically degrading biomolecules within the bioprosthetic tissue utilizing at least one of: a nuclease, a lipase, a carbohydrase, or a depolymerase; and

assembling the bioprosthetic tissue into a medical device to be implanted within a recipient;

wherein fixing the bioprosthetic tissue is to be performed prior to assembling the bioprosthetic tissue into the medical device.

2 . The method as in claim 1 , wherein the reducing agent is one of: β-mercaptoethanol (BME or 2-ME), tris(2-carboxyethyl) phosphine (TCEP), dithiothreitol (DTT), tributylphosphine (TEP of TnBP), or a combination thereof.

3 . The method as in claim 1 , wherein the nonionic detergent is one of: a polysorbate nonionic detergent, a polyethylene oxide nonionic detergent, ndodecyl-β-D-maltoside (DDM), digitonin, IGEPAL CA-630, N,N-bis[3-(Dgluconamido) propyl]cholamide (BigCHAP), or N,N-bis[3-(Dgluconamido) propyl]deoxycholamide (Deoxy Big CHAP).

4 . The method as in claim 1 , wherein the ionic detergent is one of: sodium dodecyl sulfate (SDS), sodium deoxycholate, sodium cholate, sarkosyl, or cetyltrimethylammonium bromide (CTAB).

5 . The method as in claim 1 , wherein the zwitterionic detergent is one of: amidosulfobetaine-14 (ASB-14), amidosulfobetaine-16 (ASB-16), 4-octylbenzoylamido-propyl-dimethylammoniosulfobetaine (ASB-C8o), sulfobetaine 3-10 (SB 3-10), sulfobetaine 3-12 (SB 3-12), sulfobetaine 3-14 (SB 3-14), sulfobetaine 3-16 (SB 3-16), sulfobetaine 3-18 (SB 3-18), 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate (CHAPS), 3-([3-cholamidopropyl]dimethylammonio)-2-hydroxy-1-propanesulfonate (CHAPSO), non-detergent sulfobetaine 195 (NDSB-195), non-detergent sulfobetaine 201 (NDSB-201), non-detergent sulfobetaine 211 (NDSB-211), non-detergent sulfobetaine 221 (NDSB-221), or non-detergent sulfobetaine 256 (NDSB-256).

6 . The method as in claim 1 , wherein the nuclease is one of: RNaseA, DNase I, benzonase, or a combination thereof.

7 . The method as in claim 1 , wherein the bioprosthetic tissue is animal tissue.

8 . The method as in claim 7 , wherein the animal tissue is one of: pericardium, heart valve, blood vessel, small intestinal submucosa, collagen-based tissue, or elastin-based tissue.

9 . The method as in claim 7 , wherein the animal tissue is one of: bovine, porcine, ovine, avian, or human.

10 . The method as in claim 1 , wherein fixing the bioprosthetic tissue comprises contacting with at least one crosslinking agent.

11 . The method as in claim 10 , wherein the at least one crosslinking agent is one of: formaldehyde, glutaraldehyde, paraformaldehyde, formalin, genipin, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), or a combination thereof.

12 . The method as in claim 11 further comprising stabilizing aldehyde crosslinks within the bioprosthetic tissue, wherein the stabilizing aldehyde crosslinks comprises treating with heat for an extended period of time.

13 . The method as in claim 10 , wherein the at least one crosslinking agent comprises formaldehyde, glutaraldehyde, paraformaldehyde, or formalin, and the method further comprising: capping free aldehydes within the bioprosthetic tissue.

14 . The method of claim 13 , wherein the capping free aldehydes comprises treating with a reducing agent, an amine, or a combination thereof.

15 . The method claim 1 , further comprising: treating the bioprosthetic tissue with a solution for dry storage.

16 . The method as in claim 15 , wherein the solution for dry storage comprises a glycerol, polyethylene glycol, or a saccharide.

17 . The method as in claim 15 , wherein the solvent for the solution for dry storage is aqueous based or alcohol based.

18 . The method as in claim 16 , wherein the solution for dry storage comprises a percentage of glycerol selected from about: 50%, 60%, 70%, 80%, 90%, or 100%.

19 . The method of claim 1 , wherein assembling the bioprosthetic tissue into a medical device comprises:

forming leaflets using the bioprosthetic tissue, wherein the leaflets are assembled into a heart valve.

20 . A method to prepare a bioprosthetic tissue for clinical or preclinical use, comprising:

performing one or more of:

solubilizing hydrophilic biomolecules within a bioprosthetic tissue utilizing a reducing agent;

solubilizing lipophilic biomolecules within the bioprosthetic tissue utilizing a zwitterionic detergent; and

enzymatically degrading biomolecules within the bioprosthetic tissue utilizing at least one of: a nuclease, a lipase, a carbohydrase, or a depolymerase;

fixing the bioprosthetic tissue;

treating the bioprosthetic tissue with a solution for dry storage or wet storage, wherein the solution for dry storage comprises a glycerol, polyethylene glycol, or a saccharide, wherein the solution for wet storage comprises propylene oxide;

wherein fixing the bioprosthetic tissue is to be performed before treating the biological with a solution for dry storage or wet storage.

21 . A method to prepare a bioprosthetic tissue for clinical or preclinical use, comprising:

solubilizing hydrophilic biomolecules within a bioprosthetic tissue utilizing a reducing agent;

solubilizing lipophilic biomolecules within the bioprosthetic tissue utilizing a zwitterionic detergent,

enzymatically degrading biomolecules within the bioprosthetic tissue utilizing at least one of: a nuclease, a lipase, a carbohydrase, or a depolymerase

fixing the bioprosthetic tissue with formaldehyde, glutaraldehyde, paraformaldehyde, or formalin; and

capping free aldehydes within the bioprosthetic tissue, wherein the capping free aldehydes is to be performed after fixing the bioprosthetic tissue with formaldehyde, glutaraldehyde, paraformaldehyde, or formalin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2024
From: TIAN, BIN; DE LA FUENTE, ANGELA B.; WRIGHT, GREGORY A.; HAN, JINGJIA; SHANG, HAO
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 066260/0247 →
Continuity (3)
Continuation PCTUS2020063728 · Dec 8, 2020
Provisional Application 62945721 · Dec 9, 2019
Related Publication 20220296779A1 · Sep 22, 2022
References Cited (270)
US 2393580A · Weiskopf · 1946 [cited by applicant]
US 4120649A · Schechter · 1978 [cited by applicant]
US 4323358A · Lentz et al. · 1982 [cited by applicant]
US 4350492A · Wright et al. · 1982 [cited by applicant]
US 4372743A · Lane · 1983 [cited by applicant]
US 4378224A · Nimni et al. · 1983 [cited by applicant]
US 4402697A · Pollock et al. · 1983 [cited by applicant]
US 4405327A · Pollock · 1983 [cited by applicant]
US 4481009A · Nashef · 1984 [cited by applicant]
US 4553974A · Dewanjee · 1985 [cited by applicant]
US 4624822A · Arru et al. · 1986 [cited by applicant]
US 4647283A · Carpentier et al. · 1987 [cited by applicant]
US 4648881A · Carpentier et al. · 1987 [cited by applicant]
US 4758151A · Arru et al. · 1988 [cited by applicant]
US 4770665A · Nashef · 1988 [cited by applicant]
US 4776853A · Klement et al. · 1988 [cited by applicant]
US 4786287A · Nashef et al. · 1988 [cited by applicant]
US 4838888A · Nashef · 1989 [cited by applicant]
US 4865871A · Livesey et al. · 1989 [cited by applicant]
US 4885005A · Nashef et al. · 1989 [cited by applicant]
US 4958008A · Petite et al. · 1990 [cited by applicant]
US 4976733A · Girardot · 1990 [cited by applicant]
US 5002566A · Carpentier et al. · 1991 [cited by applicant]
US 5051401A · Sikes · 1991 [cited by applicant]
US 5080670A · Imamura et al. · 1992 [cited by applicant]
US 5094661A · Levy et al. · 1992 [cited by applicant]
US 5104405A · Nimni · 1992 [cited by applicant]
US 5116564A · Jansen et al. · 1992 [cited by applicant]
US 5147514A · Mechanic · 1992 [cited by applicant]
US 5154007A · Piunno et al. · 1992 [cited by applicant]
US 5200399A · Wettlaufer et al. · 1993 [cited by applicant]
US 5215541A · Nashef et al. · 1993 [cited by applicant]
US 5279612A · Eberhardt · 1994 [cited by applicant]
US 5329846A · Bonutti · 1994 [cited by applicant]
US 5397353A · Oliver et al. · 1995 [cited by applicant]
US 5437287A · Phillips et al. · 1995 [cited by applicant]
US 5447536A · Girardot et al. · 1995 [cited by applicant]
US 5460962A · Kemp · 1995 [cited by applicant]
US 5476516A · Seifter et al. · 1995 [cited by applicant]
US 5509932A · Keogh et al. · 1996 [cited by applicant]
US 5558875A · Wang · 1996 [cited by applicant]
US 5595571A · Jaffe et al. · 1997 [cited by applicant]
US 5613982A · Goldstein · 1997 [cited by applicant]
US 5645587A · Chanda et al. · 1997 [cited by applicant]
US 5674298A · Levy et al. · 1997 [cited by applicant]
US 5697972A · Kim et al. · 1997 [cited by applicant]
US 5713953A · Vallana et al. · 1998 [cited by applicant]
US 5720777A · Jaffe et al. · 1998 [cited by applicant]
US 5720894A · Neev et al. · 1998 [cited by applicant]
US 5733339A · Girardot et al. · 1998 [cited by applicant]
US 5746775A · Levy et al. · 1998 [cited by applicant]
US 5766520A · Bronshtein · 1998 [cited by applicant]
US 5769780A · Hata et al. · 1998 [cited by applicant]
US 5782914A · Schankereli · 1998 [cited by applicant]
US 5782931A · Yang et al. · 1998 [cited by applicant]
US 5843180A · Jaffe et al. · 1998 [cited by applicant]
US 5843181A · Jaffe et al. · 1998 [cited by applicant]
US 5855620A · Bishopric et al. · 1999 [cited by applicant]
US 5862806A · Cheung · 1999 [cited by applicant]
US 5873812A · Ciana et al. · 1999 [cited by applicant]
US 5899936A · Goldstein · 1999 [cited by applicant]
US 5911951A · Girardot et al. · 1999 [cited by applicant]
US 5919472A · Trescony et al. · 1999 [cited by applicant]
US 5921980A · Kirn · 1999 [cited by applicant]
US 5931969A · Carpentier et al. · 1999 [cited by applicant]
US 5935168A · Yang et al. · 1999 [cited by applicant]
US 5945319A · Keogh · 1999 [cited by applicant]
US 5977153A · Camiener · 1999 [cited by applicant]
US 5993844A · Abraham et al. · 1999 [cited by applicant]
US 6008292A · Lee et al. · 1999 [cited by applicant]
US 6017741A · Keogh · 2000 [cited by applicant]
US 6093530A · McIlroy et al. · 2000 [cited by applicant]
US 6106555A · Yang · 2000 [cited by applicant]
US 6117979A · Hendriks et al. · 2000 [cited by applicant]
US 6121041A · Mirsch, II et al. · 2000 [cited by applicant]
US 6132472A · Bonutti · 2000 [cited by applicant]
US 6132473A · Williams et al. · 2000 [cited by applicant]
US 6132986A · Pathak et al. · 2000 [cited by applicant]
US 6156030A · Neev · 2000 [cited by applicant]
US 6156531A · Pathak et al. · 2000 [cited by applicant]
US 6165215A · Rottenberg et al. · 2000 [cited by applicant]
US 6166184A · Hendriks et al. · 2000 [cited by applicant]
US 6174331B1 · Moe et al. · 2001 [cited by applicant]
US 6177514B1 · Pathak et al. · 2001 [cited by applicant]
US 6190407B1 · Ogle et al. · 2001 [cited by applicant]
US 6193749B1 · Schroeder et al. · 2001 [cited by applicant]
US 6203755B1 · Odland · 2001 [cited by applicant]
US 6206917B1 · Williams et al. · 2001 [cited by applicant]
US 6210957B1 · Carpentier et al. · 2001 [cited by applicant]
US 6214054B1 · Cunanan et al. · 2001 [cited by applicant]
US 6214055B1 · Simionescu et al. · 2001 [cited by applicant]
US 6231608B1 · Stone · 2001 [cited by applicant]
US 6231614B1 · Yang · 2001 [cited by applicant]
US 6251579B1 · Moore et al. · 2001 [cited by applicant]
US 6254635B1 · Schroeder et al. · 2001 [cited by applicant]
US 6267786B1 · Stone · 2001 [cited by applicant]
US 6277555B1 · Duran et al. · 2001 [cited by applicant]
US 6287338B1 · Sarnowski et al. · 2001 [cited by applicant]
US 6293970B1 · Wolfinbarger, Jr. et al. · 2001 [cited by applicant]
US 6302909B1 · Ogle et al. · 2001 [cited by applicant]
US 6312474B1 · Francis et al. · 2001 [cited by applicant]
US 6322593B1 · Pathak et al. · 2001 [cited by applicant]
US 6328762B1 · Anderson et al. · 2001 [cited by applicant]
US 6334873B1 · Lane et al. · 2002 [cited by applicant]
US 6352708B1 · Duran et al. · 2002 [cited by applicant]
US 6364905B1 · Simpson et al. · 2002 [cited by applicant]
US 6375680B1 · Carlyle · 2002 [cited by applicant]
US 6383732B1 · Stone · 2002 [cited by applicant]
US 6391538B1 · Vyavahare et al. · 2002 [cited by applicant]
US 6394096B1 · Constantz · 2002 [cited by applicant]
US 6448076B2 · Dennis et al. · 2002 [cited by applicant]
US 6468660B2 · Ogle et al. · 2002 [cited by applicant]
US 6471723B1 · Ashworth et al. · 2002 [cited by applicant]
US 6479079B1 · Pathak et al. · 2002 [cited by applicant]
US 6482199B1 · Neev · 2002 [cited by applicant]
US 6506339B1 · Girardot et al. · 2003 [cited by applicant]
US 6509145B1 · Torrianni · 2003 [cited by applicant]
US 6534004B2 · Chen et al. · 2003 [cited by applicant]
US 6547827B2 · Carpentier et al. · 2003 [cited by applicant]
US 6561970B1 · Carpentier et al. · 2003 [cited by applicant]
US 6569200B2 · Wolfinbarger, Jr. et al. · 2003 [cited by applicant]
US 6582464B2 · Gabbay · 2003 [cited by applicant]
US 6589591B1 · Mansouri et al. · 2003 [cited by applicant]
US 6605667B1 · Badejo et al. · 2003 [cited by applicant]
US 6617142B2 · Keogh et al. · 2003 [cited by applicant]
US 6630001B2 · Duran et al. · 2003 [cited by applicant]
US 6652594B2 · Francis et al. · 2003 [cited by applicant]
US 6653062B1 · DePablo et al. · 2003 [cited by applicant]
US 6682559B2 · Myers et al. · 2004 [cited by applicant]
US 6696074B2 · Dai et al. · 2004 [cited by applicant]
US 6734018B2 · Wolfinbarger, Jr. et al. · 2004 [cited by applicant]
US 6753181B2 · Atala · 2004 [cited by applicant]
US 6790229B1 · Berreklouw · 2004 [cited by applicant]
US 6797000B2 · Simpson et al. · 2004 [cited by applicant]
US 6872226B2 · Cali et al. · 2005 [cited by applicant]
US 6878168B2 · Carpentier et al. · 2005 [cited by applicant]
US 6908591B2 · MacPhee et al. · 2005 [cited by applicant]
US 6911043B2 · Myers et al. · 2005 [cited by applicant]
US 6919172B2 · DePablo et al. · 2005 [cited by applicant]
US 7008763B2 · Cheung · 2006 [cited by applicant]
US 7029434B2 · Carpentier et al. · 2006 [cited by applicant]
US 7037333B2 · Myers et al. · 2006 [cited by applicant]
US 7063726B2 · Crouch et al. · 2006 [cited by applicant]
US 7078163B2 · Torrianni · 2006 [cited by applicant]
US 7141064B2 · Scott et al. · 2006 [cited by applicant]
US 7143769B2 · Stoltz et al. · 2006 [cited by applicant]
US 7214344B2 · Carpentier et al. · 2007 [cited by applicant]
US 7238200B2 · Lee et al. · 2007 [cited by applicant]
US 7318998B2 · Goldstein et al. · 2008 [cited by applicant]
US 7338757B2 · Wolfinbarger, Jr. et al. · 2008 [cited by applicant]
US 7354749B2 · Fisher et al. · 2008 [cited by applicant]
US 7367969B2 · Stoltz et al. · 2008 [cited by applicant]
US RE40570E · Carpentier et al. · 2008 [cited by applicant]
US 7498565B2 · Silberberg et al. · 2009 [cited by applicant]
US 7579381B2 · Dove · 2009 [cited by applicant]
US 7594974B2 · Cali et al. · 2009 [cited by applicant]
US 7648676B2 · Mills et al. · 2010 [cited by applicant]
US 7682304B2 · Heyninck-Jantz et al. · 2010 [cited by applicant]
US 7914569B2 · Nguyen et al. · 2011 [cited by applicant]
US 7919112B2 · Pathak et al. · 2011 [cited by applicant]
US 7972376B1 · Dove et al. · 2011 [cited by applicant]
US 8007992B2 · Tian et al. · 2011 [cited by applicant]
US 8038708B2 · Case et al. · 2011 [cited by applicant]
US 8043450B2 · Cali et al. · 2011 [cited by applicant]
US 8075615B2 · Eberhardt et al. · 2011 [cited by applicant]
US 8105375B2 · Navia et al. · 2012 [cited by applicant]
US 8136218B2 · Millwee et al. · 2012 [cited by applicant]
US 8308797B2 · Paniagua et al. · 2012 [cited by applicant]
US 8361144B2 · Fish et al. · 2013 [cited by applicant]
US 8377143B2 · Hamby et al. · 2013 [cited by applicant]
US 8475827B2 · Hamby et al. · 2013 [cited by applicant]
US 10383978B2 · Dong et al. · 2019 [cited by applicant]
US 10722613B2 · Ashworth et al. · 2020 [cited by applicant]
US 20010000804A1 · Goldstein et al. · 2001 [cited by applicant]
US 20010025196A1 · Chinn et al. · 2001 [cited by applicant]
US 20010027344A1 · Bonutti · 2001 [cited by applicant]
US 20010032024A1 · Cunanan et al. · 2001 [cited by applicant]
US 20010039459A1 · Stone · 2001 [cited by applicant]
US 20020001834A1 · Keogh et al. · 2002 [cited by applicant]
US 20020091441A1 · Guzik · 2002 [cited by applicant]
US 20020111532A1 · Pathak et al. · 2002 [cited by applicant]
US 20030035843A1 · Livesey et al. · 2003 [cited by applicant]
US 20030125805A1 · Johnson et al. · 2003 [cited by applicant]
US 20030135284A1 · Crouch et al. · 2003 [cited by applicant]
US 20030167089A1 · Lane · 2003 [cited by applicant]
US 20030212454A1 · Scott et al. · 2003 [cited by applicant]
US 20040030381A1 · Shu · 2004 [cited by applicant]
US 20040086543A1 · Keogh et al. · 2004 [cited by applicant]
US 20040158320A1 · Simionescu et al. · 2004 [cited by applicant]
US 20050010773A1 · Lapstun et al. · 2005 [cited by applicant]
US 20050119736A1 · Zilla et al. · 2005 [cited by applicant]
US 20050136510A1 · Hendriks et al. · 2005 [cited by applicant]
US 20050211680A1 · Li et al. · 2005 [cited by applicant]
US 20060084957A1 · Delfyett et al. · 2006 [cited by applicant]
US 20060099326A1 · Keogh et al. · 2006 [cited by applicant]
US 20060110370A1 · Pathak et al. · 2006 [cited by applicant]
US 20060159641A1 · Girardot et al. · 2006 [cited by applicant]
US 20060193885A1 · Leonard Neethling et al. · 2006 [cited by applicant]
US 20060210960A1 · Livesey et al. · 2006 [cited by applicant]
US 20060217804A1 · Dove · 2006 [cited by applicant]
US 20060217805A1 · Dove · 2006 [cited by applicant]
US 20070050014A1 · Johnson · 2007 [cited by applicant]
US 20070073392A1 · Heyninck-Jantz et al. · 2007 [cited by applicant]
US 20070203576A1 · Lee et al. · 2007 [cited by applicant]
US 20070254005A1 · Pathak et al. · 2007 [cited by applicant]
US 20080302372A1 · Davidson et al. · 2008 [cited by applicant]
US 20080319166A1 · Shen · 2008 [cited by applicant]
US 20090041729A1 · Wolfinbarger, Jr. et al. · 2009 [cited by applicant]
US 20090130162A2 · Pathak et al. · 2009 [cited by applicant]
US 20090137999A1 · Silberberg et al. · 2009 [cited by applicant]
US 20090188900A1 · Cali et al. · 2009 [cited by applicant]
US 20090326524A1 · Cali et al. · 2009 [cited by applicant]
US 20100036484A1 · Hariton et al. · 2010 [cited by applicant]
US 20110092966A1 · Guo et al. · 2011 [cited by applicant]
US 20110177150A1 · Pathak et al. · 2011 [cited by applicant]
US 20110214398A1 · Liburd et al. · 2011 [cited by applicant]
US 20110238167A1 · Dove et al. · 2011 [cited by applicant]
US 20110295363A1 · Girard et al. · 2011 [cited by applicant]
US 20110300625A1 · Paniagua et al. · 2011 [cited by applicant]
US 20110306124A1 · Strasly et al. · 2011 [cited by applicant]
US 20110311493A1 · Dove et al. · 2011 [cited by applicant]
US 20120035720A1 · Cali et al. · 2012 [cited by applicant]
US 20120059487A1 · Cunanan et al. · 2012 [cited by applicant]
US 20120067855A1 · Guo et al. · 2012 [cited by applicant]
US 20120078356A1 · Fish et al. · 2012 [cited by applicant]
US 20120095551A1 · Navia et al. · 2012 [cited by applicant]
US 20120123557A1 · Carpentier et al. · 2012 [cited by applicant]
US 20120185038A1 · Fish et al. · 2012 [cited by applicant]
US 20120328905A1 · Guo et al. · 2012 [cited by applicant]
US 20130122583A1 · Neethling · 2013 [cited by applicant]
US 20130238088A1 · Navia et al. · 2013 [cited by applicant]
US 20130243738A1 · Griffiths · 2013 [cited by examiner]
US 20150088247A1 · L'Heureux et al. · 2015 [cited by applicant]
US 20170173214A1 · Wang et al. · 2017 [cited by applicant]
US 20190374680A1 · Lehenberger et al. · 2019 [cited by applicant]
CN 103705980A · 2014 [cited by applicant]
CN 106390202A · 2017 [cited by applicant]
EP 0169259A1 · 1986 [cited by applicant]
EP 2394673A1 · 2011 [cited by applicant]
WO 8401894A1 · 1984 [cited by applicant]
WO 9511047A1 · 1995 [cited by applicant]
WO 9522361A1 · 1995 [cited by applicant]
WO 9534332A1 · 1995 [cited by applicant]
WO 9613227A1 · 1996 [cited by applicant]
WO 9807452A1 · 1998 [cited by applicant]
WO 9843556A1 · 1998 [cited by applicant]
WO 0032252A1 · 2000 [cited by applicant]
WO 2004082536A1 · 2004 [cited by applicant]
WO 2006026325A2 · 2006 [cited by applicant]
WO 2006099334A2 · 2006 [cited by applicant]
WO 2011132089A2 · 2011 [cited by applicant]
WO 2013009851A2 · 2013 [cited by applicant]
Carpentier, A., et al., “Biological Factors Affecting Long-Term Results of Valvular Heterografts,” Forty-ninth Meeting of the American Association for Thoracic Surgery, San Francisco, CA, Mar. 31-Apr. 2, 1969. [cited by applicant]
Chanda, J., et al., “Heparin in Calcification Prevention of Porcine Pericardial Bioprostheses,” Biomaterials, Elsevier Science Publishers, vol. 18, No. 16, ISSN: 0142-9612, Aug. 1, 1997. [cited by applicant]
Chvapil, M., et al., “Use of Chemically Purified And Cross-Linked Bovine Pericardium As A Ligament Substitute,” Journal of Biomedical Materials Research, vol. 21, No. 12, pp. 1383-1394, 1987, University of Arizona Healt… [cited by applicant]
Dahm, Manfred, et al., “Effects of Surface Seeding with Vital Cells on the Calcium Uptake of Biological Materials for Heart Valve Replacement,” J Heart Valve Dis, vol. 5, No. 2, Mar. 1996, 148-151. [cited by applicant]
Fahner, P., et al., “Systematic Review of Preservation Methods and Clinical Outcome of Infrainguinal Vascular Allografts,” Journal of Vascular Surgery, vol. 44, No. 3, pp. 518-524, 2006. [cited by applicant]
Fumoto, H., et al., “Performance of Bioprosthetic Valves After Glycerol Dehydration, Ethylene Oxide Sterilization, and Rehydration,” Innovations, vol. 6, No. 1, Jan./ Feb. 2011. [cited by applicant]
Grabenwoger, M. et al. “Decreased Tissue Reaction to Bioprosthetic Heart Valve Material after L-glutaimc acid Treatment. A Morphological Study.” J. Biomed Mater. Res. Sep. 1992;26(9):1231-40. [cited by applicant]
Grant, R.A., et al., “The Effects of Irradiation with High Energy Electrons on the Structure and Reactivity of Native and Cross-Linked Collagen Fibres,” J. Cell Sci. vol. 7, 99. 387-405, 1970. [cited by applicant]
Hauschka, P., et al., “Direct Identification of the Calcium- Binding Amino Acid, y-Carboxyglutamate, in Mineralized Tissue,” Proc. Nat. Acad. Sci, vol. 72, No. 10, pp. 3925-3929, Oct. 1975. [cited by applicant]
Jayakrishnan, A., et al., “Glutaraldehyde as a Fixative in Bioprostheses and Drug Delivery Matrices,” Biomaterials, vol. 17, Issue 5, 1996, pp. 471-484. [cited by applicant]
Khora, Eugene, “Methods for the Treatment of Collagenous Tissues for Bioprostheses,” Biomaterials, vol. 18, Issue 2, Jan. 1997, pp. 95-105. [cited by applicant]
Liao, K., et al., “Mechanical Stress: An Independent Determinant of Early Bioprosthetic Calcification in Humans,” Ann. Throac. Surg 2008;86:491-495. [cited by applicant]
Neethling, W., et al., “Enhanced Biostability and Biocompatibility of Decellularized Bovine Pericardium, Crosslinked with an Ultra-Low Concentration Monomeric Aldehyde and Treated with ADAPT®,” J. Heart Valve Dis. 2008;… [cited by applicant]
R Parker, et al. Storage of Heart Valve Allografts in Glycerol With Subsequent Antibiotic Sterilisation, Thorax, 1978, 638-645, vol. 33:5, British Thoracic Society, London, UK. [cited by applicant]
Saegeman, V., et al., “Short and long term bacterial inhibiting effect of high concentrations of glycerol used in the prevention of skin allografts,” Science Direct, Burns, No. 34, Mar. 2008. [cited by applicant]
Schmidt, C., et al., “Acellular Vascular Tissues: Natural Biomaterials for Tissue Repair and Tissue Engineering,” Biomaterials, vol. 21, pp. 2215-2231, 2000. [cited by applicant]
Trantina-Yates AE, et al. “Detoxification of Top Enhanced, Diamine-Extended Glutaraldehyde Fixation Significantly Reduces Bioprosthetic Root Calcification in the Sheep Model,” J. Heart Valve Dis. Jan. 2003; 12 (1):93-10… [cited by applicant]
Zilla, P., et al., “Carbodiimide Treatment Dramatically Potentiates the Anticalcific Effect of Alpha-Amino Oleic Acid on Glutaraldehyde-Fixed Aortic Wall Tissue,” The Annals of Thoracic Surgery, Elsevier, vol. 79, No. 3… [cited by applicant]